Gold Sponsor

We are specialists in orphan drug access, partnering with our clients to achieve launch success worldwide. Through our initiatives, we are able to inform and shape the conversation of orphan drugs. Our expert team is specialised in several key areas to optimize price and access potential. Our focus areas include: orphan drug pricing and market access strategy; bespoke access roadmap; rare disease foresights; evidence mitigation solutions; access team excellence. As one of the only consultancies with comprehensive experience in cell and gene therapies, we are excellently placed to help you with your commercialization plans.
At P4A, we believe in striking an equilibrium in the rare disease world. That means helping drive access to the most appropriate treatments for patients and physicians, a fair return on investment for manufacturers at an affordable proposition for payers
Enlightened. Thinking. Applied


Follow us on


Sign Up for Event Updates

Get Involved At World Orphan Drug Congress 2019


To Sponsor Or Exhibit


Michael Hodge
t/ +44 20 7092 1091


To Speak


Wing-Yun Cheung
t/ +44 20 7092 1172


To Register


Issa Mauthoor
t/ +44 20 7092 1257